KOLs Supportive of GOSS Data & Position in PAH Market
Insights - Last week, Gossamer (GOSS) hosted a KOL call to discuss their Phase 2 results, OLE data and upcoming Phase 3 design. Below are notes from … Continue Reading
Read nowSearch Results for gene therapy
Transcript of Gossamer (GOSS) OLE Data Call
Transcripts - Bryan Giraudo Good morning, everyone. Thank you for joining us for our Seralutinib Program update discussion about PROSERA’s Phase III design and interim TORREY results. … Continue Reading
Read now
Transcript of BridgeBio (BBIO) Phase 3 ATTR-CM Call
Transcripts - Operator Good day, and thank you for standing by. Welcome to today’s discussion with BridgeBio, which will cover the company’s top line 30-month results from … Continue Reading
Read now
Transcript of Nanobiotix & Janssen Licensing for NBTXR3
Transcripts - Operator Good day, and thank you for standing by. Welcome to the Nanobiotix License Agreement with Janssen Pharmaceutica NV, one of Janssen Pharmaceutical Companies of … Continue Reading
Read now
Transcript of Genfit (GNFT) & Ipsen (IPN) Phase III Call for Cholangitis
Transcripts - Operator Good day, and welcome to the GENFIT Positive Top Line Data from Phase III ELATIVE trial of elafibranor in patients with Primary Biliary Cholangitis … Continue Reading
Read now
Radiopharmaceutical Progress Overlooked with ADC Dominating Spotlight
Insights - Radiopharmaceutical companies are primed for increased investor interest as the sector is seeing meaningful progress that is currently being overlooked in favor of ADCs. Tailwinds … Continue Reading
Read now
Transcript of BioXcel (BTAI) Phase 3 for Alzheimer’s Agitation
Transcripts - Operator Good morning, and welcome to the BioXcel Therapeutics TRANQUILITY II Top Line Results Conference Call. [Operator Instructions] Just to remind everyone, certain matters discussed … Continue Reading
Read now